2
Clinical Trials associated with Rosuvastatin Calcium/Gemigliptin L-tartrate SesquihydrateA Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics, Safety, and Tolerability of the Combination of Gemigliptin/Rosuvastatin 50/20 mg in Comparison to Each Component Gemigliptin 50 mg and Rosuvastatin 20 mg Administered in Healthy Male Volunteers
This study is to evaluate the safety/tolerability and pharmacokinetics of the combinations of gemigliptin 50mg and rosuvastatin 20mg in comparison to each component administered alone in healthy male volunteers.
A Multicenter, Randomized, Placebo-controlled, Double-blind, Phase III Trial to Evaluate the Efficacy and Safety of the Fix-dose Combination Therapy With Gemigliptin 50mg and Rosuvastatin 20mg With Type 2 Diabetes and Dyslipidemia
To evaluate the efficacy and safety of the fix-dose combination therapy with Gemigliptin 50mg and Rosuvastatin 20mg with type 2 diabetes and dyslipidemia
100 Clinical Results associated with Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate
100 Translational Medicine associated with Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate
100 Patents (Medical) associated with Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate
100 Deals associated with Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate